Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Stilbene. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112661611A reveals a novel KI-catalyzed route for Benvitimod, eliminating toxic halogenation and enabling scalable, cost-effective API manufacturing.
Advanced catalytic dehydrogenation method for iminostilbene production featuring solvent recycling and water conservation for cost-effective API manufacturing.
Patent CN102503763A details a high-selectivity Heck reaction for stilbene synthesis. This method offers superior regioselectivity and yield for reliable pharmaceutical intermediates supply.
Patent CN105152973B reveals a novel stilbene derivative with reversible fluorescence. Offers supply chain stability and simplified synthesis for electronic chemical manufacturing.
Patent CN1301246C details novel 1-cyano-1-(3,5-dimethoxyphenyl)-2-phenylethylene synthesis. Offers superior antitumor potential and scalable manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN103086969B analysis reveals improved bromination efficiency. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114957122A details a green synthesis route for 10-methoxyiminostilbene, featuring waste valorization into potassium bromide and solvent recycling for cost-effective manufacturing.
Patent CN105693521A reveals a novel catalytic bromination method enhancing stability and purity for high-performance agrochemical intermediates and flame retardants.
Novel synthesis method for Pterostilbene phosphate disodium salt. High yield, mild conditions, scalable production for pharmaceutical applications.
Novel one-pot synthesis for heat-resistant energetic materials improves yield significantly. Reliable supplier for high-purity intermediates with scalable production capabilities.
Patent CN106748662B reveals a high-yield synthetic route for Oxyresveratrol, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108276267B details a novel synthesis for fluorine-containing 1,1-stilbene derivatives. This route offers enhanced metabolic stability and scalable manufacturing for oncology drug development.
Novel five-step synthesis route for 10-methoxyiminostilbene offers mild conditions and high purity. Enhances supply chain stability and reduces manufacturing costs significantly.
Patent CN116768709B reveals a green synthesis route for 2-hydroxystilbenes. Offers high purity, scalable manufacturing, and cost-effective supply chain solutions for global buyers.
Patent CN102276426A reveals a novel ligand-free Heck coupling method for trans-resveratrol. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103012292A reveals a novel 2-step synthesis for dibenzo[b,f][1,2]diazocine, offering >50% yield and eliminating toxic mercury residues for reliable pharmaceutical intermediate supply.
Discover the biomass-derived synthesis of Benvitimod intermediates. This patent offers a green, scalable route with recyclable catalysts for cost-effective pharmaceutical manufacturing.
Novel patent CN103288737B details high-yield iminostilbene synthesis. Reduces steps and pollution for reliable pharmaceutical intermediates supplier cost efficiency.
Patent CN108586211B reveals a cost-effective Pd-catalyzed decarboxylative coupling method for 1,1-diarylethene derivatives, offering significant supply chain advantages.
Novel microwave-assisted method for trans-stilbene intermediates reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners globally.